Indaptus Therapeutics | DEFA14A: Others
Apr 26 21:08
Indaptus Therapeutics | DEF 14A: Definitive information statements
Apr 26 21:03
Indaptus Therapeutics | 8-K: Current report
Mar 25 20:33
Indaptus Therapeutics | 424B5: Prospectus
Mar 14 05:05
Indaptus Therapeutics | 10-K: Annual report
Mar 13 20:03
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Mar 13 20:03
Indaptus Therapeutics | 8-K: Current report
Mar 5 00:05
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Newman Michael James
Jan 23 13:00
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A
Jan 23 13:00
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sassi Nir
Jan 23 13:00
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.
Jan 23 13:00
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Linscott Walt Addison
Jan 23 13:00
Indaptus Therapeutics | 8-K: Current report
Jan 23 13:00
Indaptus Therapeutics: Q3 2023 Earnings Report
Nov 7, 2023 05:06
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Nov 7, 2023 05:05
Indaptus Therapeutics | 8-K: Current report
Nov 6, 2023 21:13
Indaptus Therapeutics | 8-K: Current report
Oct 31, 2023 21:12
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Anderson Glen R.
Aug 17, 2023 06:01
Indaptus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glen R. Anderson(14.17%)
Aug 17, 2023 05:57
Indaptus Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 20:15
No Data
No Data